サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/13 | 2,645 | 2,824 | 2,612 | 2,755 | +108 | +4.1% | 3,773,700 |
| 2025/08/12 | 2,748 | 2,849 | 2,642 | 2,647 | -80 | -2.9% | 4,209,400 |
| 2025/08/08 | 2,643 | 2,755 | 2,603 | 2,727 | +76 | +2.9% | 4,447,800 |
| 2025/08/07 | 2,467 | 2,708 | 2,427 | 2,651 | +206 | +8.4% | 6,397,100 |
| 2025/08/06 | 2,518 | 2,538 | 2,432 | 2,445 | -50 | -2% | 2,375,300 |
| 2025/08/05 | 2,350 | 2,500 | 2,346 | 2,495 | +160 | +6.9% | 2,912,100 |
| 2025/08/04 | 2,300 | 2,378 | 2,267 | 2,335 | -25 | -1.1% | 1,675,800 |
| 2025/08/01 | 2,286 | 2,406 | 2,275 | 2,360 | +45 | +1.9% | 2,582,400 |
| 2025/07/31 | 2,267 | 2,352 | 2,242 | 2,315 | +63 | +2.8% | 2,407,300 |
| 2025/07/30 | 2,307 | 2,310 | 2,195 | 2,252 | -54 | -2.3% | 2,201,700 |
| 2025/07/29 | 2,269 | 2,364 | 2,245 | 2,306 | +81 | +3.6% | 3,383,400 |
| 2025/07/28 | 2,341 | 2,356 | 2,220 | 2,225 | -143 | -6% | 3,288,000 |
| 2025/07/25 | 2,330 | 2,386 | 2,271 | 2,368 | +61 | +2.6% | 3,819,900 |
| 2025/07/24 | 2,214 | 2,340 | 2,183 | 2,307 | +143 | +6.6% | 3,394,600 |
| 2025/07/23 | 2,105 | 2,229 | 2,104 | 2,164 | +62 | +2.9% | 1,975,800 |
| 2025/07/22 | 2,148 | 2,215 | 2,102 | 2,102 | -11 | -0.5% | 1,873,400 |
| 2025/07/18 | 2,135 | 2,184 | 2,092 | 2,113 | -20 | -0.9% | 1,236,600 |
| 2025/07/17 | 2,082 | 2,162 | 2,082 | 2,133 | +52 | +2.5% | 1,552,600 |
| 2025/07/16 | 2,128 | 2,129 | 2,064 | 2,081 | -55 | -2.6% | 1,794,600 |
| 2025/07/15 | 2,185 | 2,333 | 2,125 | 2,136 | -31 | -1.4% | 3,411,500 |
| 2025/07/14 | 2,176 | 2,196 | 2,106 | 2,167 | +1 | ±0% | 1,445,700 |
| 2025/07/11 | 2,210 | 2,359 | 2,143 | 2,166 | -49 | -2.2% | 4,370,800 |
| 2025/07/10 | 2,086 | 2,280 | 2,075 | 2,215 | +136 | +6.5% | 6,209,500 |
| 2025/07/09 | 2,070 | 2,133 | 2,051 | 2,079 | +20 | +1% | 1,855,600 |
| 2025/07/08 | 2,129 | 2,153 | 2,040 | 2,059 | -60 | -2.8% | 1,856,600 |
| 2025/07/07 | 2,164 | 2,267 | 2,110 | 2,119 | -52 | -2.4% | 2,502,700 |
| 2025/07/04 | 2,180 | 2,214 | 2,126 | 2,171 | +10 | +0.5% | 2,138,400 |
| 2025/07/03 | 2,233 | 2,277 | 2,156 | 2,161 | -13 | -0.6% | 2,301,700 |
| 2025/07/02 | 2,242 | 2,282 | 2,166 | 2,174 | -158 | -6.8% | 2,884,500 |
| 2025/07/01 | 2,362 | 2,418 | 2,318 | 2,332 | -77 | -3.2% | 3,429,100 |
| 2025/06/30 | 2,181 | 2,463 | 2,174 | 2,409 | +248 | +11.5% | 9,672,700 |
| 2025/06/27 | 2,131 | 2,255 | 1,995 | 2,161 | -220 | -9.2% | 12,190,700 |
| 2025/06/26 | 2,431 | 2,497 | 2,381 | 2,381 | -500 | -17.4% | 4,440,600 |
| 2025/06/25 | 2,757 | 2,954 | 2,682 | 2,881 | +138 | +5% | 4,609,100 |
| 2025/06/24 | 2,794 | 2,806 | 2,671 | 2,743 | -77 | -2.7% | 2,797,800 |
| 2025/06/23 | 2,665 | 2,902 | 2,641 | 2,820 | +79 | +2.9% | 4,353,900 |
| 2025/06/20 | 2,721 | 2,865 | 2,653 | 2,741 | +120 | +4.6% | 6,178,800 |
| 2025/06/19 | 2,880 | 2,948 | 2,573 | 2,621 | -276 | -9.5% | 6,115,700 |
| 2025/06/18 | 2,850 | 2,971 | 2,802 | 2,897 | -58 | -2% | 4,305,400 |
| 2025/06/17 | 3,220 | 3,300 | 2,952 | 2,955 | -265 | -8.2% | 3,775,900 |
| 2025/06/16 | 3,380 | 3,445 | 3,105 | 3,220 | -230 | -6.7% | 3,727,100 |
| 2025/06/13 | 3,620 | 3,630 | 3,450 | 3,450 | -105 | -3% | 2,134,300 |
| 2025/06/12 | 3,650 | 3,725 | 3,530 | 3,555 | -125 | -3.4% | 1,988,400 |
| 2025/06/11 | 3,680 | 3,800 | 3,625 | 3,680 | -20 | -0.5% | 3,243,000 |
| 2025/06/10 | 3,485 | 3,720 | 3,460 | 3,700 | +280 | +8.2% | 3,979,700 |
| 2025/06/09 | 3,315 | 3,480 | 3,265 | 3,420 | +40 | +1.2% | 2,179,600 |
| 2025/06/06 | 3,515 | 3,595 | 3,350 | 3,380 | -140 | -4% | 2,283,700 |
| 2025/06/05 | 3,650 | 3,660 | 3,445 | 3,520 | -140 | -3.8% | 4,089,600 |
| 2025/06/04 | 3,370 | 3,805 | 3,340 | 3,660 | +290 | +8.6% | 9,996,200 |
| 2025/06/03 | 3,290 | 3,380 | 3,155 | 3,370 | +150 | +4.7% | 3,732,800 |
1～
50
件表示中 / 2529件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 275,500円 | - | - | 0.00% | - | 127.61倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 155,400円 | +5.0% | +1.5% | 0.00% | 13.30倍 | 3.74倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 433,500円 | +3.6% | - | 2.77% | 14.61倍 | 0.86倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 390,000円 | -6.4% | -71.8% | 4.87% | 43.43倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
